SEC Tracker
Get the app

Aligos Therapeutics ALGS

Aligos Therapeutics: reports an exchange listing deficiency notice and reports an executive or board change

Form
8-K
Filed
Period
Importance
Major
Document
8-K
  • Reports an exchange listing deficiency notice (3.01)
  • Reports an executive or board change (5.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Aligos Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Estrella Immunopharma ESLA public float $20M, Mar 12, 2026
  2. CEL-SCI CVM public float $19M, Mar 31, 2025, over 18 months old
  3. Armata Pharmaceuticals ARMP public float $21M, Jun 30, 2025
  4. BioAtla BCAB public float $19M, Jun 30, 2025
  5. Cognition Therapeutics CGTX public float $18M, Jun 30, 2025